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Physics, Arizona State University, Tempe, ArizonaABSTRACT Cyanovirin-N (CVN), a cyanobacterial lectin, exemplifies a class of antiviral agents that inhibit HIV by binding to
the highly glycosylated envelope protein gp120. Here, we investigate the energetics of glycan recognition using a computation-
ally inexpensive flexible docking approach, backbone perturbation docking (BP-Dock). We benchmarked our method using two
mutants of CVN: P51G-m4-CVN, which binds dimannose with high affinity through domain B, and CVN(mutDB), in which binding
to domain B has been abolished through mutation of five polar residues to small nonpolar side chains. We investigated the
energetic contribution of these polar residues along with the additional position 53 by docking dimannose to single-point CVN
mutant models. Analysis of the docking simulations indicated that the E41A/G and T57A mutations led to a significant decrease
in binding energy scores due to rearrangements of the hydrogen-bond network that reverberated throughout the binding cavity.
N42A decreased the binding score to a level comparable to that of CVN(mutDB) by affecting the integrity of the local protein struc-
ture. In contrast, N53S resulted in a high binding energy score, similar to P51G-m4-CVN. Experimental characterization of the
five mutants by NMR spectroscopy confirmed the binding affinity pattern predicted by BP-Dock. Despite their mostly conserved
fold and stability, E41A, E41G, and T57A displayed dissociation constants in the millimolar range. N53S showed a binding con-
stant in the low micromolar range, similar to that observed for P51G-m4-CVN. No binding was observed for N42A. Our results
show that BP-Dock is a useful tool for rapidly screening the relative binding affinity pattern of in silico-designed mutants
compared with wild-type, supporting its use to design novel mutants with enhanced binding properties.INTRODUCTIONCyanovirin-N (CVN), a 101 aa lectin isolated from Nostoc
ellipsosporum, exemplifies a novel class of therapeutic
agents that target the surface glycans of HIV and other en-
veloped viruses (1–7). Its potent activity against HIV is
mediated by high-affinity binding to the mannose-rich gly-
cans that decorate the surface of gp120, and requires multi-
valent interactions through two binding domains within the
protein (8–12). CVN is unique among lectins in recognizing
a glycan unit, Mana(1,2)Mana, with high affinity and spec-
ificity: glycan array analysis reveals that only mannose-rich
structures containing the specific glycosidic linkage a-Man-
(1,2)-a-Man are recognized (13,14). For these reasons, the
protein is emerging as a convenient model system for inves-
tigating glycan-protein interactions and testing computa-
tional approaches to glycan recognition.
The structure of CVN reveals a novel (to our knowledge)
b-sheet fold that comprises two quasi-symmetric domains,
defined as A (residues 1–38/90–101) and B (residues 39–
89), connected on each side by a short 310 helix. Despite a
backbone root mean-square standard deviation (RMSD) of
0.76 A˚, the two domains are ~25% identical in sequence, re-
sulting in slightly different glycan selectivity and affinity.
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0006-3495/14/03/1142/10 $2.00preference for linear trimannose in domain A, and a
preference for dimannose (Mana(1,2)Mana) in domain B
(1–7,9,15–21). Domain B is generally considered the high-
affinity binding site: the reported binding constants are in
good agreement and show low-micromolar affinity for
Mana(1,2)Mana (8–12,15,16,22,23). Structural data for
CVN and mutants containing an intact domain B in the apo
and dimannose-bound forms (8,9,13–15,18,19,23), comple-
mented by binding studies using oligomannose derivatives
(24), contributed to mapping the key interactions in the
glycan recognition event on both the protein and the glycan.
The origins of the unique specificity and high affinity of WT
CVN for dimannose are poorly understood (25). In partic-
ular, the energetic contribution of backbone versus side-
chain interactions, and the role of water-mediated hydrogen
bonds in determining binding affinity are still under debate.
Here, we analyzed glycan binding by CVN and its mu-
tants by applying a flexible docking approach called back-
bone perturbation docking (BP-Dock), which is based on
perturbation response scanning (PRS), a method that com-
bines elastic network models with linear response theory
(26–29). This approach accurately predicted binding affinity
patterns of the PDZ domain of PICK1 with various PDZ
motifs (29). BP-Dock enabled us to integrate backbone
and side-chain conformational changes of the protein, as
well as the flexibility of the glycan ligand, in the docking
analysis, which is crucial for accurate prediction of binding
affinity (29). Compared with computationally expensivehttp://dx.doi.org/10.1016/j.bpj.2014.01.040
Binding-Energy Determinants of Glycan-CVN 1143traditional molecular-dynamics (MD) calculations per-
formed on CVN (20,30–32), this method allows for rapid
in silico screening of a series of mutants.
For simplicity, we limited our analysis to the high-affinity
site, domain B. We benchmarked our method by comparing
two well-characterized mutants of CVN (Fig. 1): one that
comprises an intact domain B (Fig. 1 B) and one in which
binding to domain B has been abolished (Fig. 1 C). The
computed binding affinities are consistent with high-affinity
binding for one, and with no binding for the other. Extend-
ing our docking analysis to single mutants of P51G-m4-
CVN, we observed that some mutations led to less favorable
binding-energy scores, whereas others did not. Based on
these predictions, we experimentally characterized five
mutants and obtained binding affinities in agreement with
the predictions.
Our work demonstrates that rapid docking can be an effi-
cient tool for predicting binding-affinity patterns of various
mutants in glycan recognition. However, the method relies
on accurate prediction of the initial unbound mutant struc-
ture. With such tools, it should be possible to predict muta-
tions that change affinity and specificity for given glycan
targets.MATERIALS AND METHODS
Benchmark
We analyzed bound mutant structures of P51G-m4-CVN (8,9) and
CVN(mutDB) (16) in this study. The crystal structures for P51G-m4-CVN
(PDB code: 2RDK) and CVN(mutDB) (PDB code: 3CZZ) were retrieved
from the Protein Data Bank (http://www.rcsb.org/pdb) (33). These struc-
tures were used as templates for binding affinities to dimannose sugar in
our flexible docking simulations.Modeling of single point mutant structures
We first checked the possible impact of single point mutations on the local
structure, or the overall stability of the protein. By analyzing the hydrogen-
bond network of each individual site within the binding pocket, we found
that the side chains of some residues, such as Asn-42 and Thr-57, made crit-
ical hydrogen bonds with the backbone or side chain of other positions of
CVN (Table S1 in the Supporting Material). Thus, mutating these positionsto Ala could alter the stability or lead to local structural change. To capture
those effects, we introduced the point mutations into the x-ray structure via
Swiss PDB Viewer (34), and performed short (3 ns) replica-exchange MD
(REMD) simulations to obtain well-equilibrated mutant models. The initial
point mutant structure was seeded into the REMD (35) simulation, and the
temperature of the replicas ranged from 270 K to 450 K. Replica spacing
was set such that the swap likelihood between replicas approached 0.45.
The AMBER force field (ff99SB) (36) with a generalized Born implicit sol-
vent (37) model and a solvent-accessible penalty term of 5 cal/mol A˚ was
used. An a-carbon covariance matrix was calculated from a 1 ns window
of the trajectory, and the convergence was checked by the observed high
correlation between the slowest fluctuation profiles of the two successive
windows. After clustering the snapshots of the lowest replica, we used
the most dominant structure (i.e., the lowest free-energy state) as the pre-
dicted mutant model structure.PRS
When a ligand (i.e., dimannose sugar) approaches a receptor (CVN mu-
tants), it exerts force on the binding site, inducing conformational changes.
In this work, as a first-order approximation, we mimicked this by applying
small random forces on the protein and then computing the displacement of
each residue through PRS (26,38). As a matter of fact, the most intriguing
aspect of the BP-Dock approach is that it generates a wide range of binding-
induced conformations realized in nature by exerting random unit forces on
each residue in the sequence without the presence of ligand. This enabled us
to integrate the conformational changes of the receptor (CVN mutants) in
the docking analysis, which in turn increased the accuracy of the binding
predictions. Thus, ensembles for P51G-m4-CVN, CVN(mutDB), and the in-
dividual domain B mutant models were obtained by PRS. PRS is a coarse-
grained approach that couples elastic network models with linear response
theory (26,28,39). Previously, we have shown that PRS can 1), capture
conformational changes upon binding (26); 2), identify key residues that
mediate long-range communication and find allosteric pathways (28);
and 3), discriminate disease-associated mutants from neutral ones (40).
We compared the dynamics of PRS, which is based on a coarse-grained
approach, with those obtained from all-atom MD simulations, and these
two estimates showed high correlations (28,40). However, PRS requires
four orders of magnitude less CPU time than MD simulations. Furthermore,
although convergence is a bottleneck for MD simulations of larger proteins,
it is not an issue in the case of PRS. Therefore, PRS is a fast and efficient
approach to incorporate backbone flexibility (27–29), which most of the
conventional docking protocols cannot do because it is a computationally
expensive and difficult procedure.
In the model, the protein structure is viewed as a 3D elastic network
in which the Ca atom acts as the nodes and identical springs connect the
interacting a-carbons. We applied a random unit force, F, in a random
direction to the a-carbon atom of each residue one at a time (i.e., perturba-
tion of a single residue in the chain with a random Brownian kick)FIGURE 1 (A) Crystal structure of P51G-m4-
CVN (PDB ID: 2RDK) with dimannose bound.
(B) Domain B of P51G-m4-CVN, with residues
focused on in this study highlighted in yellow
(blue, nitrogen atoms; red, oxygen atoms). (C)
Domain B of CVN(mutDB) (PDB ID: 3CZZ), with
residues that differ from those of P51G-m4-CVN
highlighted in yellow. Domain B of CVN(mutDB)
does not bind dimannose. (D) The sequences of
the two mutants are shown aligned with domain
A (black) and domain B (gray). The differences be-
tween P51G-m4-CVN and CVN(mutDB) in domain
B are highlighted. To see this figure in color, go
online.
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1144 Bolia et al.sequentially along the chain. The perturbation cascaded through the
residue interaction network of the protein and caused other amino acid
positions to respond. By using the PRS method, we computed this fluctua-
tion response as a profile, in both direction and magnitude. Thus, the
response vector, DR, gave the deviation of each residue from its mean
position in the x, y, and z directions upon perturbation. This procedure
indeed mimicked the natural process of protein binding interactions in a
cell as a first approximation, since an approaching ligand applies forces
on the receptor protein, inducing conformational change. To minimize
the effects of randomness, we performed this procedure 10 times to ensure
that the force applied was isotropic and the response vector was averaged.
These response fluctuation profiles were used to generate low-resolution
multiple receptor conformations (MRCs) based on Ca atoms. If DF is a
3N1 vector that contains the components of the externally applied force
on the selected residues, and H is the Hessian, a 3N  3N matrix composed
of the second derivatives of the potential with respect to the components of
the position vectors, we can calculate the response of the elastic network of
residues using Eq. 1:
½DR3N 1 ¼
½H3N 3N1½DF3N 1 (1)
where DR is the 3N-dimensional vector of the response fluctuations of all
the residues.To derive the perturbed structure, we calculated the final perturbed coor-
dinates for each residue as follows:
Rper

3N 3N ¼ ½R03N 1 þ a½DR3N 1 (2)
where R0 is the vector showing initial coordinates of the residues before
perturbation, and a is a scaling factor with a value of 50. The arbitrary valueof 50 was chosen such that it could yield structures in a range of 0.5–2.0 A˚
RMSD from the original (unperturbed) crystal structure (28,41).
The perturbed structures were then clustered to discard similar conforma-
tions generated from the perturbations on different residues in the protein.
The perturbed structures generated from PRS varied from each other and
had a backbone RMSD of 0.58–2.15 A˚ relative to the initial structure.
Once the backbone was perturbed, coarse-grained conformations were
obtained by integrating the response fluctuation profile into the original
Cartesian coordinates; the side chains were derived from the original unper-
turbed structure. An all-atom minimization of these structures was done
using the AMBER package (42,43) to account for the fluctuation in the
side chains upon perturbation on the backbone of the protein and to relieve
strain in the system. Another way to couple the side-chains to the perturbed
backbone conformations is to update the side-chain positions using the in-
ternal coordinates of the initial structure and then follow up by energy mini-
mization. We tested this approach for 2RDK and the E41A and E41G
mutants. However, the RMSD between the conformations obtained after
minimization with and without updated internal coordinates were in the
range of 0.26–0.49 A˚ for 2RDK, 0.03–0.2 A˚ for E41A, and 0.27–0.43 A˚
for E41G. We also observed that the docking results did not show any sig-
nificant difference compared with results from the minimization approaches
discussed above (Table S2). This could be because side-chain conforma-
tions are again repacked using either rotamer trials or a full combinatorial
search in RosettaLigand (44,45).Docking with RosettaLigand
An ensemble docking using PRS-generated conformations was performed
with RosettaLigand (44,45). The docking simulations for each structure in
the ensemble were performed using the RosettaLigand protocol in the
ROSETTA package. RosettaLigand is a method that was specifically
developed for docking ligands into protein-binding sites. This method
incorporates ligand flexibility by changing torsional angles and the back-
bone of the ligand, whereas the whole protein is held fixed throughout
the docking simulation. In each case, the coordinates of the dimannoseBiophysical Journal 106(5) 1142–1151sugar were taken from the crystallographic complex of 2RDK and were
treated as a single residue. The ligand was represented as a set of discrete
conformations and the docking procedure, ensuring that the ensembles
spun a maximal range of the conformational space (45). In this study, we
perturbed the ligand position and orientation randomly with the translation
of mean 0.1 A˚ and rotations of mean 3, respectively. The rigid-body orien-
tation and side-chain c angles of the ligand were optimized using the
gradient-based Davidson-Fletcher-Powell algorithm (44,45). Each docking
trajectory consisted of 50 of the Monte Carlo minimization cycles, and we
computed 10,000 trajectories to generate a comprehensive ensemble of
conformations of the receptor-glycan complex for each protein. The forma-
tion of a distinct binding funnel in energy score/RMSD plots was consid-
ered as an indication of successful docking, and the final docked
conformations were selected based on the lowest free-energy pose in the
protein-binding site. The lowest free-energy pose had the lowest Ligsum
score among all other docking poses (Ligsum is a RosettaLigand scoring
function composed of five energy terms: attractive, repulsive, solvation,
hydrogen bonding, and coulombic (44,45)). The overall flexible docking
approach is outlined in Fig. 2. The binding energies of the bound complexes
with the lowest Ligsum score were evaluated with X-Score. X-Score is an
empirical scoring function that was developed to rerank the protein-ligand
complex and give a more accurate estimate of the binding free energies,
which have been found to correlate with the experimental binding
constants (46).Protein cloning, expression, and purification
Mutagenic primers were used to introduce the E41A, E41G, T57A, N42A,
and N53S single mutations into a P51G-m4-CVN sequence in a pET26b(þ)
vector and then transformed into BL21(DE3) cells (Novagen, Madison,
WI). Proteins were expressed as previously described (9). Briefly,
100 mL cell cultures were incubated overnight at 37C, and then 10 mL
of this culture was added to a 1 L of lysogeny broth (LB). For NMR exper-
iments, a modified M9 minimal media containing 15NH4Cl (Cambridge
Isotope Laboratories, Andover, MA) as the sole nitrogen source was used
in place of LB. Cells were induced with addition of 1 mM isopropyl
b-D-1-thiogalactopyranoside when the OD600 reached 0.8 and were grown
overnight at 37C, and harvested via centrifugation. The cell pellet was
lysed by sonication and the insoluble fraction was solubilized using an
8 M urea buffer. The 6 histidine-tagged proteins were purified on a GE
HisTrap HP column (GE Healthcare Bio-Sciences, Piscataway, NJ) using
a Bio-Rad EconoPump (Bio-Rad, Richmond, CA) under denaturing condi-
tions. Proteins were refolded by dialysis into a 2 M urea buffer, pH 8.0, at
room temperature for 12 h, and then overnight into 10 mM Tris, 100 mM
NaCl, pH 8.0, replacing the Tris buffer once. The protein secondary struc-
ture and stability were verified by circular dichroism (CD) on a JASCO
J-815 CD spectrometer (JASCO, Easton, MD). Temperature denaturation
experiments were performed by following the molar ellipticity at 202 nm
of samples containing 20 mM protein in 15 mM potassium phosphate;
samples were heated over a range of 4–90C at 1C/min with a data pitch
of 0.5C.NMR titrations
Purified 15N-labeled protein was buffer exchanged by gel filtration with a
GE HiLoad 16/600 Superdex 75 pg column (GE Healthcare Bio-Sciences)
on an Agilent 1260 BIO-inert HPLC system (Agilent Technologies, Santa
Clara, CA) into 20 mM sodium phosphate buffer, pH 6.0. Fractions contain-
ing the monomer of the protein were pooled and concentrated using
Amicon Ultracel-3K centrifugal filters (Millipore, Billerica, MA) to
300 mM protein.
Aliquots from a stock solution of 2a-mannobiose (Sigma Aldrich,
St. Louis, MO) were titrated into the protein. 1H-15N heteronuclear single
quantum coherence (HSQC) spectra were obtained on a Varian Innova
FIGURE 2 Flow chart of the flexible docking method. In our flexible
docking approach using the PRS model, we generate an ensemble of recep-
tor conformations through several steps: (i) sequentially exerting random
external force on each single-residue of the CVN mutants, (ii) calculating
the response fluctuation vector using the PRS method, (iii) constructing
the low-resolution deformed structures (i.e., backbone) using the response
vectors after each single residue perturbation, (iv) clustering the perturbed
conformations using the k-clustering method, and (v) all-atom minimiza-
tion of each clustered conformation. Once the MRCs ensemble is
completed, we perform a docking simulation using the RosettaLigand
option in the ROSETTA package for each minimized structure in the
ensemble. (vi) Lastly, the binding energies of the CVN-dimannose com-
plexes with the lowest Ligsum score are evaluated using X-Score. To see
this figure in color, go online.
Binding-Energy Determinants of Glycan-CVN 1145500 MHz spectrometer equipped with a room-temperature triple-resonance
probe at gradually increasing molar ratios of ligand to protein. Chemical
shifts were observed and the Dd were determined according to Eq. 3
(47,48):Dd ¼ ðDdHNÞ2 þ ð0:17  DdNÞ21 =2 (3)
The chemical shifts were plotted against the molar ratio ([ligand]/[protein])
and fitted to Eq. 4:
Dd ¼ 0:5þ Ddmax
0
@M þ 1þ Kd½P

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
M þ 1þ Kd½P
2
 4M
s 1
A
(4)
RESULTS
Our analysis focused on domain B, which has higher affinity
and specificity for dimannose (Mana(1,2)Mana) in WT
CVN, and for which extensive mutational analysis is
available. We used two engineered forms of CVN, P51G-
m4-CVN and CVN(mutDB), which present the two extremes
of the binding affinity range: P51G-m4-CVN contains a
wild-type (WT) domain B and thus binds dimannose
with high affinity (8,9), whereas CVN(mutDB) contains an
impaired domain B and thus does not bind dimannose at
concentrations as high as millimolar (49). P51G-m4-CVN
and CVN(mutDB) each contain a P51G mutation in the hinge
region that stabilizes the monomeric form relative to the
domain-swapped form of CVN (50). The two mutants
have been thoroughly characterized, with crystal structures
available for CVN(mutDB) (16) and for P51G-m4-CVN in
its apo and bound forms (8,9).
Using the crystallographic coordinates as a starting
point, we generated ensembles of binding-induced confor-
mations by subjecting each protein to PRS. Specifically,
we first obtained backbone conformational changes upon
perturbing different positions with a random force. We
generated the full-atom models by adding the side chains
and performing an all-atom minimization for each confor-
mation in the ensemble. We used RosettaLigand to dock
the dimannose ligand into the cavity or binding pocket
for each structure in the ensemble, and scored the lowest-
energy poses as described in Materials and Methods. The
binding energy of dimannose to domain B of P51G-m4-
CVN calculated by X-Score is 7.58 kcal/mol and the
RMSD of the ligand obtained from the lowest-energy
docked pose is only 0.19 A˚. In contrast, analysis of
CVN(mutDB) shows a drastic change in the binding energy
making it less favorable (4.68 kcal/mol), corresponding
to a change in dissociation constant of four orders of
magnitude, and a ligand RMSD of 0.38 A˚ obtained from
the lowest-energy docked pose. Fig. 3 compares the
binding profiles of P51G-m4-CVN and CVN(mutDB) for
dimannose, and the docking profile observed for P51G-
m4-CVN indicates a well-converged distinct binding fun-
nel. In contrast, CVN(mutDB) shows a poor docking profileBiophysical Journal 106(5) 1142–1151
FIGURE 3 RosettaLigand energy scores (in kcal/mol) versus the RMSD
of the docked complex for CVN mutants and dimannose sugar. P51G-m4-
CVN (2RDK) is shown in blue circles and CVN(mutDB) (3CZZ) is shown in
red squares. The funnel shape of the graph indicates good docking for
P51G-m4-CVN. In agreement with experiments, P51G-m4-CVN-diman-
nose has a significantly low binding-energy score (17.25 kcal/mol),
whereas the complex of CVN(mutDB) (9.28 kcal/mol) does not. To see
this figure in color, go online.
1146 Bolia et al.in which energetically degenerate structures have high
RMSDs.
Next, we analyzed each residue’s energetic contribution
to binding by systematically mutating each position in
P51G-m4-CVN to the corresponding amino acid in
CVN(mutDB): Glu-41, Asn-42, Thr-57, Arg-76 were changed
to Ala, and Gln-78 was changed to Gly. We also mutated
residue 41 to glycine, which is the most common substitu-
tion at that position in the CVN-homologous family of pro-
teins, CVNH (13,51). In addition to the positions mutated in
CVN(mutDB), we mutated N53, which lines the binding
pocket and interacts with the glycan, to serine, because
serine is the most common substitution at this position in
CVNH (13,51).
In the absence of crystal structures for the mutants, we
generated starting models by introducing the individual
point mutations into the coordinates of P51G-m4-CVN
and performing a short REMD run (3 ns). Starting from
the most dominant structure of the lowest-temperatureTABLE 1 Binding energy scores (Ebind) evaluated from X-Score alo
protein side chain positions in the binding site (RMSDsidechain) of the l
Higher negative values indicate a higher binding affinity prediction.
Protein RMSDligand (A˚) RMSDside chain (A˚
P51Gm4CVN 0.19 0.189
CVN(mutDB) 0.38 1.866
E41A 0.74 1.155
E41G 0.82 1.261
N42A 1.08 1.808
T57A 0.99 1.08
R76A 1.06 1.036
Q78G 0.98 0.845
N53S 0.88 1.365
Biophysical Journal 106(5) 1142–1151REMD run (i.e., the structure with the lowest free energy),
we applied our flexible docking approach to each mutant
(see Materials and Methods for details). The mutations at
positions 41, 42, and 57 resulted in decreased affinity
compared with that of P51G-m4-CVN (Table 1). Position
42 accounts for most of the loss of binding energy between
the intact domain B in P51G-m4-CVN and the defective
domain B in CVN(mutDB): the X-Score binding energy of
N42A (5.37 kcal/mol) is in close proximity to the non-
binder CVN(mutDB) (i.e., 4.68 kcal/mol). This drastic loss
in binding energy score may indicate the critical role of
N42 in stabilizing the structure of the binding pocket. The
side chain of N42 forms hydrogen bonds to the backbone
of neighboring residues (Table S1); further, this position is
very well conserved in the CVNH family (13,46). T57A,
E41A, and E41G also showed a significant decrease in bind-
ing affinity, albeit not as drastic as that observed for N42A.
In contrast, the binding energy score of N53S mutant
(7.06 kcal/mol) is comparable to that of P51G-m4-CVN
(7.58 kcal/mol). To verify the accuracy of our predictions,
we recombinantly expressed E41A, E41G, T57A, N42A,
and N53S on the background of P51G-m4-CVN (8,9), and
subjected them to experimental characterization.Effect of single point mutations on fold and
stability of CVN
We confirmed that the mutants are monomers, similar to the
parent construct, using size exclusion chromatography. The
elution profiles of P51G-m4-CVN and the mutants each
exhibit a main peak at 89 mL, which accounts for over
80% of the total protein; small peaks at 70 mL correspond
to dimer (Fig. S1). We assigned monomer and dimer peaks
by comparing the elution profiles with those of recombinant
WT CVN, in which the ratio of domain-swapped dimer to
monomer is ~40:60 (9,50).
The mutations do not affect the overall secondary and ter-
tiary structure of P51G-m4-CVN, as assessed by CD spec-
troscopy and 2D-NMR. The CD spectra of the mutants are
identical to that of P51G-m4-CVN, indicating mainly b
structure, with a characteristic minimum at 212 nm and
maximum at 190 nm (Fig. S2). The 1H-15N HSQCng with corresponding RMSDs of the ligand (RMSDligand) and
owest energy docked pose for various CVNmutants are shown.
) X-Score Ebind (kcal/mol) Experimental Kd
7.58 low mM
4.68 no binding (49)
6.7 5415 118 mM
6.82 3895 73 mM
5.37 no binding
6.46 low mM
6.9 NA
6.85 NA
7.06 low mM
Binding-Energy Determinants of Glycan-CVN 1147correlation spectra of isotopically labeled mutants show that
the backbone amide resonances are well dispersed in both
dimensions and resemble the spectrum of P51G-m4-CVN
(Fig. 4, P51G-m4-CVN; Fig. 5, E41A and E41G, red
spectra; Figs. S3–S5 for N42A, T57A, and N53S, respec-
tively). Taken together, the spectroscopic results demon-
strate that the mutants display the hallmarks of native
proteins, and are consistent with the conservation of the
CVN fold.
We assessed the thermodynamic stability of each mutant
by thermal denaturation, monitoring the loss of secondary
structure at increasing temperatures from 4C to 90C by
CD at 202 nm, the wavelength at which the largest change
is observed between folded and unfolded spectra. The ther-
mal denaturation of WT CVN and its mutants is not revers-
ible, which precludes a rigorous analysis of the folding
thermodynamics. It is possible, however, to compare the
thermal denaturation profiles of a series of mutants and
calculate the apparent midpoint of the melting transitions
(Tm). The melting curves of the mutants (Fig. 6) show
that, with the exception of T57A and N42A, the single point
mutations do not affect protein stability significantly. The
apparent melting points Tm are shown in Table 2.Binding to dimannose (Man2)
We used 2D-NMR spectroscopy to quantify the binding of
dimannose to P51G-m4-CVN and each of the mutants, by
monitoring the changes in chemical shift of the backbone
amide signals in uniformly labeled proteins upon addition of
ligand through 1H-15N-correlation spectroscopy (HSQC).
This technique is particularly well suited for measuring
dissociation constants in the mid- to high-micromolar range
(52). Titrations were carried out by adding dimannose from
a stock solution up to at least a 15 molar equivalent in
300 mM protein. A comparison of the 1H-15N HSQC spectra
of the P51G-m4-CVN before (red) and after (black) addi-
tion of 12.5 molar equivalents of dimannose is reported in
Fig. 4. The 1H-15N HSQC spectra resulting from the titra-FIGURE 4 1H-15N HSQC spectra of P51G-m4-CVN without dimannose
(red) and with 12.5 molar equivalents of dimannose (black). To see this
figure in color, go online.tion of increasing amounts of dimannose (red to black
color) into E41A and E41G are shown in Fig. 5, A and B,
respectively. The binding isotherms derived by plotting
changes in normalized chemical shifts (Dd, ppm) of
selected resonances as a function of added dimannose are
shown in Fig. 5, C and D. As expected, P51G-m4-CVN
bound tightly to dimannose, and the changes in chemical-
shift signals saturated upon addition of slightly more than
one equivalent. In contrast, addition of dimannose to
E41A and E41G resulted in much weaker binding. The
monitored chemical-shift changes reached saturation only
upon addition of several excess equivalents of dimannose
(5.5 molar equivalents). We calculated the equilibrium
dissociation constants (Kd) for E41A and E41G by
analyzing the changes in chemical shifts versus ligand con-
centration for several resonances, as described in Materials
and Methods. This analysis yielded Kd values of 541 5
118 mM for E41A, and 389 5 74 mM for E41G. For
T57A, the chemical-shift changes were initially small (<2
molar equivalents) and did not reach saturation even after
the addition of 15 molar equivalents (Fig. S4). This
behavior suggests a Kd in the low millimolar range.
N42A did not show any binding to dimannose, as no change
in chemical shift was observed in molar equivalents up to
20 (Fig. S3). In contrast, binding of dimannose to P51G-
m4-CVN displayed the hallmark of tight binding and
occurred in fast-to-intermediate exchange mode in the
NMR timescale. This behavior prevented an accurate deter-
mination of Kd by NMR. Consistent with the computational
predictions, N53S behaved similarly to P51G-m4-CVN,
and binding was in intermediate exchange (Fig. S5). In
both cases, analysis of the spectra revealed that the protein
was saturated upon addition of one equivalent of diman-
nose, and further addition of ligand did not result in changes
in the signals.DISCUSSION
Computationally intensive explicit-solvent MD simulations
along with Poisson-Boltzmann-based calculations have
been used to evaluate binding free energies and analyze
binding interaction networks, using dimannose and triman-
nose as ligands. Most computational studies have focused
on WT CVN (17,20,53) and P51G-m4-CVN (21,54). The
calculated binding energies, in general, reproduced experi-
mental values reported in the literature. Explicit-solvent
MD simulations indicated the critical role of water and
the flexibility of the binding pocket in the binding free
energy calculations (20), which were later confirmed exper-
imentally (8,9). These computational studies showed that
several hydrogen-bond interactions originate from the back-
bone amides and carbonyl moieties (21,54); however, some
side-chain hydrogen-bond interactions were also observed,
especially in a-Man-(1,2)-a-Man-(1,2)-a-Man (trimannose)
recognition (53).Biophysical Journal 106(5) 1142–1151
FIGURE 5 1H-15N HSQC spectra of (A) E41A
and (B) E41G from titrations with increasing
amounts of dimannose (red to black). The reso-
nances are well dispersed and resemble that of
the P51G-m4-CVN spectrum, indicating the two
mutants are well folded. Example plots and fitting
of molar equivalents versus normalized peak shift
are shown for a single resonance (E41A in C;
E41G in D). The average Kd values from the fits
for E41A and E41G are 541 mM and 389 mM,
respectively. To see this figure in color, go online.
1148 Bolia et al.Despite the wealth of structural and computational data
available for WT CVN and its mutants, the role of main-
chain interactions versus side-chain interactions in stabiliz-
ing CVN-dimannose complexes remained unclear. Here, we
extended our flexible docking protocol to the analysis of di-
mannose recognition in CVN, using two engineered variants
(P51G-m4 and CVNmutDB) as benchmarks. We generated
backbone-perturbed conformations of CVN mutants by
applying random unit forces to individual residues in a
sequential manner. We then performed an all-atom minimi-
zation after adding the side chains to the backbone-per-
turbed structures to account for any rotamer changes of
the side chains and to relieve any strain in the structure, asFIGURE 6 Thermal denaturation profiles of E41A (red circles), E41G
(black squares), N53S (green triangles), T57A (blue upside-down trian-
gles), and N42A (orange diamonds). The unfolding transitions were moni-
tored at 202 nm from 4C to 90C using 20 mMprotein in 15 mM potassium
phosphate. The melting points are 53C, 55C, 53C, 50.6C, and 48C,
respectively. To see this figure in color, go online.
Biophysical Journal 106(5) 1142–1151perturbations on the backbone can lead to significant
changes in the orientation of the side chains. To understand
the drastic decrease in binding affinity of CVN(mutDB) rela-
tive to P51G-m4-CVN, we analyzed the hydrogen-bond
network in the lowest-energy docked poses of P51G-
m4-CVN-dimannose and CVN(mutDB)-dimannose using
Chimera with a cutoff of 4.0 A˚. This approach is commonly
used in docking studies to roughly estimate critical ligand-
receptor interactions (55). The network for the P51G-
m4-CVN-dimannose complex comprises of main-chain
nitrogen atoms of Asn-42 and Asp-44 as donors; main-chain
oxygen atoms of Asn-42, Ser-52, Asn-53, and Lys-74 as
acceptors; and side-chain Og of Thr-57 as both acceptor
and donor (Fig. 7 A). This hydrogen-bond network is similar
to the hydrogen-bond network identified in previous studies
(54,56). In addition, we observed side-chain hydrogen-
bonding interactions of OE2 of Glu-41 as acceptor, and
NE of Arg-76, NH2 of Arg-76, and NE2 of Gln-78 as donor
with the dimannose (Fig. 7 A), which was previously seen
only in the case of trimannose binding (53). CVN(mutDB)TABLE 2 Melting temperatures of the proteins used in this
study
Protein Tm (
C)
P51G-m4-CVN 59
E41A 53.4
E41G 55.3
N53S 53.6
T57A 50.6
N42A 48.2
The proteins unfold irreversibly, preventing a rigorous analysis of folding
thermodynamics.
FIGURE 7 Main-chain and side-chain hydrogen-bond networks for the
lowest-energy docked pose of (A) P51G-m4-CVN, (B) N42A, (C) E41A,
(D) T57A, and (E) N53S. The dimannose sugar is shown in cyan, the
residues that form a hydrogen bond with the sugar are shown in yellow,
and the hydrogen bond is shown in magenta. To see this figure in color,
go online.
Binding-Energy Determinants of Glycan-CVN 1149retained all of the main-chain hydrogen bonds at Ala-42,
Asp-44, Ser-52, Asn-53, and Lys-74; in contrast, all side-
chain hydrogen-bonding interactions observed in P51G-
m4-CVN were lost. Only one side-chain hydrogen bond,
with OE1 of Glu-56 as acceptor, was observed for
CVN(mutDB). These results emphasize the critical role
played by side-chain interactions of residues 41, 57, 76,
and 78 in dimannose.
A comparison of the hydrogen-bond networks of the
E41A, N42A, and T57A mutants with that of the P51G-
m4-CVN-dimannose complex showed rearrangements in
main-chain and side-chain networks. Specifically, in
N42A-dimannose, the main-chain hydrogen bond interac-tions of the nitrogen of Asn-42 and Asp-44 as donors, and
oxygen of Lys-74 as acceptor were lost. The side-chain in-
teractions of OE2 Glu-41, NE and NH2 of Arg-76, and
NE2 Gln-78 were lost; however, the side-chain interactions
of OD1 Asp-44 and OD1 Asn-53 were gained, preserving
the interaction with OG1 of Thr-57 (Fig. 7 B). In E41A-di-
mannose, the main-chain carbonyl oxygen of Lys-74 as
acceptor was lost and another oxygen of Ser-52 and Asn-
53 were gained as acceptors. The side-chain interactions
of OE2 Glu-41, NE and NH2 of Arg-76, NE2 Gln-78, and
OG1 of Thr-57 were lost, and OD1 Asp-44 and OD1 Asn-
53 were gained (Fig. 7 C). The T57A mutant retained all
of the main-chain hydrogen-bond interactions with diman-
nose; however, it lost all of the side-chain interactions
except OD1 of Asp-44, which explains the slightly higher
decrease in binding affinity as compared with the E41A
mutant (Fig. 7 D). E41G displayed a similar hydrogen-
bond network (Fig. S6). The analysis shows that compared
with the hydrogen-bond network of the P51G-m4-CVN-
dimannose complex, N42A lost the highest number of
hydrogen bonds (most of which were backbone hydrogen
bonds) to dimannose. The loss of hydrogen bonds in
T57A and E41A corresponded mostly to side-chain
hydrogen bonds. These findings suggest that the identity
of the side chains at positions 41 and 57 plays a critical
role in dimannose binding. Conversely, our results suggest
that N42 defines the integrity (i.e., the local stability) of the
binding pocket by making critical side-chain-to-backbone
hydrogen bonds to the neighboring b-sheet. Although
polar-to-Ala mutations have disruptive effects on binding,
we observe that conservative Asn to Ser mutation at
position 53 preserves a hydrogen-bond pattern conducive
to binding. The interactions of main-chain N of Asn-42,
OE2 of Glu-41, OG1 of Thr-57, and NE2 of Gln-78
were lost, but additional side-chain interactions of N
Asp-44, O of Ser-53, OD1 of Asp-44, and OG of Ser-53
were gained compared with P51G-m4-CVN-dimannose
(Fig. 7 E). Details of the hydrogen-bond analysis are pro-
vided in Table S3.
One common approach in ensemble docking is to use
snapshots of the MD trajectories (57,58). However, the suc-
cess of this approach depends on whether the simulation
covers the wide range of conformations sampled during
binding. To gain a better idea of whether BP-Dock can
help improve the binding affinity prediction beyond MD,
we also performed ensemble docking using clustered snap-
shots of the REMD trajectories, and compared the results
with those obtained by our flexible BP-Dock approach,
which is based on a single mutant model. The binding af-
finities obtained from ensemble MD docking (Table S4)
were all in the same range and could not really differentiate
between a binder (i.e., N53S) and a nonbinder (N42A).
Moreover, it did not capture the relative order of binding
affinity (with N53S being the strongest, the binding score
decreased in order from E41G to E41A and finally T57A,Biophysical Journal 106(5) 1142–1151
1150 Bolia et al.the weakest binder). However, BP-Dock approach captured
the relative order of binding affinities observed experimen-
tally and was capable of differentiating binders from
nonbinders.
Our biophysical characterization by CD, thermal denatur-
ation experiments, and 2D-NMR showed that the N42A and
T57A mutations slightly affected the stability of the protein.
As observed in P51G-m4-CVN, N53S bound dimannose
with dissociation constants in the low micromolar range
and in intermediate exchange conditions, indicative of tight
binding. On the other hand, a single point mutation of E41A,
E41G, and T57A resulted in much weaker dissociation con-
stants (in the low millimolar range) and in fast exchange on
the NMR timescale. However, mutation N42A abolished
binding to dimannose.
Overall, our experimental characterizations of these five
mutants show that BP-Dock can capture the binding-affinity
pattern. The X-Score binding energy scores suggest that the
mutations of E41A, E41G, and T57A resulted in a lower
binding affinity for dimannose compared with P51G-m4-
CVN, indicating the critical role of these side chains in
glycan recognition. Mutation N42A was more disruptive
than the other mutations, with a binding score closer to
that of the nonbinder CVN(mutDB).CONCLUSIONS
This work highlights the role of side-chain interactions
in stabilizing the complex of dimannose and P51G-m4-
CVN, with N42, T57, and E41 emerging as key factors
for strong binding to dimannose. As shown here, N42
also appears to stabilize the binding pocket; its absence
alters the hydrogen bond network within the protein and
the ligand, thus abolishing binding. These effects add to
other previously identified key interactions in CVN, such
as the hydrogen bond networks with the side chain of
Arg-76 (20,53) and the main-chain (54), suggesting that a
complex interplay between hydrogen bonds contributes to
the remarkable affinity and specificity of CVN for a(1,2)-
linked mannose.
The experimental verification of flexible BP-Dock sug-
gests that our approach could be utilized as an in silico
screening tool to assess the effect of mutations on the
binding affinity and specificity of CVN-based lectins as
compared with the WT.SUPPORTING MATERIAL
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